Recent Securities Litigations

Innocoll Holdings (NASDAQ: INNL)

Company Name:Innocoll Holdings
Stock Symbol:NASDAQ: INNL
Class Period Start:07/25/2014
Class Period End (inclusive):12/29/2016

According to the law firm press release, the lawsuit alleges throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Innocoll’s New Drug Application (“NDA”) submission to the FDA in October 2016 for XARACOLL was incomplete; (2) due to the incomplete NDA submission, XARACOLL would not be approved in 2017 as investors were led to believe; and (3) as a result, Defendants’ statements about Innocoll’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.